Fw: AUTO-IMMUNE Digest - 22 Sep 2003 to 23 Sep 2003 (#2003-97)

[Guest guest]

----- Original Message -----

From: " Automatic digest processor " <LISTSERV@...>

" Recipients of AUTO-IMMUNE digests " <AUTO-IMMUNE@...>

Sent: Wednesday, September 24, 2003 12:06 AM

Subject: AUTO-IMMUNE Digest - 22 Sep 2003 to 23 Sep 2003 (#2003-97)

> There are 3 messages totalling 158 lines in this issue.

>

> Topics of the day:

>

> 1. Multiple Sclerosis Resource Center

> 2. Dose and Frequency of Administration of Interferon-Beta Affect its

> Efficacy in Multiple Sclerosis

> 3. Human Coronavirus Linked With Demyelinating Disease

>

> ----------------------------------------------------------------------

>

> Date: Tue, 23 Sep 2003 15:40:47 -0400

> From: Irwin Mortman <irwin@...>

> Subject: Multiple Sclerosis Resource Center

>

> <http://mp.medscape.com/cgi-bin1/DM/y/hdeL0ECm7C0D2G0FOKH0AG>Multiple

Sclerosis

> Nearly 300,000 people in the US have multiple sclerosis (MS).

> Progress in neuroimaging and molecular medicine has provided insights

> into the disease process and new avenues for treatment, but as

> technology advances, the relationship between neuropathology and

> clinical disease process appears ever more complicated.

>

> http://www.medscape.com/pages/editorial/resourcecenters/public/ms/rc-ms.ov

>

> Registration required, but registration is at no cost.

> --

> ===========================================

> Searching the archives is available at:

>

> http://PEACH.EASE.LSOFT.COM/archives/AUTO-IMMUNE.html

> =========================================================================

> To change your E-Mail address follow the steps below:

> 1. Remove yourself from the list using old E-Mail address

> 2. Subscribe to the list with new E-mail address

> Instruction are provide below.

> =========================================================================

> If you ever want to remove yourself from this mailing list, send mail to:

>

> LISTSERV@...

>

> with the following command in the body of your email message:

>

> " SIGNOFF AUTO-IMMUNE "

>

> without the quotes

> No text is required in the Subject area.

> =========================================================================

> To subscribe to the auto-immune list send an E-mail to

>

> LISTSERV@...

>

> In the body of the E-mail type

>

> SUBscribe auto-immune " your name "

>

> Without the quotes.

>

> No text is required in the Subject area.

>

> ------------------------------

>

> Date: Tue, 23 Sep 2003 15:42:52 -0400

> From: Irwin Mortman <irwin@...>

> Subject: Dose and Frequency of Administration of Interferon-Beta Affect

its Efficacy in Multiple Sclerosis

>

> Dose and Frequency of Administration of Interferon-Beta Affect its

> Efficacy in Multiple Sclerosis

> The debate on the optimal dose and frequency of interferon-beta in

> multiple sclerosis continues. Read this author's analysis of recent

> studies.

> Clin Drug Invest 23(9) 2003

>

> http://www.medscape.com/viewarticle/460582?mpid=18898

>

> Registration required, but registration is at no cost.

> --

> ===========================================

> Searching the archives is available at:

>

> http://PEACH.EASE.LSOFT.COM/archives/AUTO-IMMUNE.html

> =========================================================================

> To change your E-Mail address follow the steps below:

> 1. Remove yourself from the list using old E-Mail address

> 2. Subscribe to the list with new E-mail address

> Instruction are provide below.

> =========================================================================

> If you ever want to remove yourself from this mailing list, send mail to:

>

> LISTSERV@...

>

> with the following command in the body of your email message:

>

> " SIGNOFF AUTO-IMMUNE "

>

> without the quotes

> No text is required in the Subject area.

> =========================================================================

> To subscribe to the auto-immune list send an E-mail to

>

> LISTSERV@...

>

> In the body of the E-mail type

>

> SUBscribe auto-immune " your name "

>

> Without the quotes.

>

> No text is required in the Subject area.

>

> ------------------------------

>

> Date: Tue, 23 Sep 2003 16:21:36 -0400

> From: Irwin Mortman <irwin@...>

> Subject: Human Coronavirus Linked With Demyelinating Disease

>

> Human Coronavirus Linked With Demyelinating Disease

> The first reported case of human coronavirus associated with acute

> disseminated encephalomyelitis (ADEM) was reported by researchers at

> the 43rd annual Interscience Conference on Antimicrobial Agents and

> Chemotherapy here on Sunday, providing further support for the

> hypothesis that human coronavirus plays a role in the pathogenesis in

> demyelinating disease in humans.

> Reuters Health Information 2003

>

> http://www.medscape.com/viewarticle/461555?mpid=18898

>

> Registration required, but registration is at no cost.

> --

> ===========================================

> Searching the archives is available at:

>

> http://PEACH.EASE.LSOFT.COM/archives/AUTO-IMMUNE.html

> =========================================================================

> To change your E-Mail address follow the steps below:

> 1. Remove yourself from the list using old E-Mail address

> 2. Subscribe to the list with new E-mail address

> Instruction are provide below.

> =========================================================================

> If you ever want to remove yourself from this mailing list, send mail to:

>

> LISTSERV@...

>

> with the following command in the body of your email message:

>

> " SIGNOFF AUTO-IMMUNE "

>

> without the quotes

> No text is required in the Subject area.

> =========================================================================

> To subscribe to the auto-immune list send an E-mail to

>

> LISTSERV@...

>

> In the body of the E-mail type

>

> SUBscribe auto-immune " your name "

>

> Without the quotes.

>

> No text is required in the Subject area.

>

> ------------------------------

>

> End of AUTO-IMMUNE Digest - 22 Sep 2003 to 23 Sep 2003 (#2003-97)

> *****************************************************************